Viz RV/LV vs VX1

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Viz.ai
VS
by Volta Medical

AI Verdict

These tools are adjacent rather than direct competitors, as they address distinct clinical challenges within cardiology. Viz RV/LV focuses on automating measurements from CTPA scans for rapid pulmonary embolism risk stratification, aiding emergency medicine and radiology. In contrast, Volta Medical's VX1 provides real-time AI guidance during atrial fibrillation and atrial tachycardia ablation procedures, assisting cardiac electrophysiologists.

Choose Viz RV/LV if…

Choose Viz RV/LV if your priority is rapid, AI-driven risk stratification for suspected pulmonary embolism directly from CTPA scans. This tool is ideal for emergency medicine and radiology departments needing automated right and left ventricular diameter measurements to quickly assess PE severity and streamline care coordination for critical patients.

View Viz RV/LV →

Choose VX1 if…

Choose VX1 if you are a cardiac electrophysiologist seeking real-time, AI-guided assistance during atrial fibrillation or atrial tachycardia ablation procedures. This software is specifically designed to enhance the identification of dispersed electrograms, aiming to improve procedural efficacy and reduce inter-operator variability in the EP lab.

View VX1 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Viz RV/LV VX1
Pricing Not publicly available Contact for pricing
Deployment Cloud-based Software integrated with existing electrophysiology (EP) lab mapping and recording systems.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz RV/LV

Viz RV/LV (Tool A) offers broad usability benefits across a care team with its cloud-based deployment, mobile DICOM viewer, AI-powered alerts, and HIPAA-compliant communication platform. These features enable seamless care coordination and streamline workflows for rapid pulmonary embolism risk stratification, making it highly accessible and integrated into a wider healthcare ecosystem.

Clinical Value

VX1

Volta Medical's VX1 (Tool B) demonstrates significant clinical value by standardizing a highly operator-dependent atrial fibrillation ablation procedure. Clinical studies have shown it reduces inter-operator variability and achieves high rates of freedom from AF and atrial arrhythmia at one-year follow-up, addressing a critical need in a complex and often recurrent condition.

Pricing & Value

Tie

Neither Viz RV/LV (Tool A) nor VX1 (Tool B) provides publicly available pricing information. Without specific cost details, it is impossible to conduct a comparative assessment of their value proposition or cost-effectiveness.

Enterprise Readiness

Viz RV/LV

Viz RV/LV (Tool A) explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), alongside robust cloud-based deployment designed for interoperability, scalability, and security. Its integration with PACS and EHRs, coupled with SOC 2 and ISO certifications, demonstrates a comprehensive approach to enterprise readiness across numerous health systems.

Innovation

VX1

Volta Medical's VX1 (Tool B) stands out for its pioneering application of real-time AI guidance directly during complex cardiac ablation procedures. By analyzing 3D anatomical and electrical maps to identify specific electrogram abnormalities and standardize outcomes, it represents a significant and interactive leap in interventional cardiology.

Support & Docs

Viz RV/LV

Viz.ai (Tool A) offers a comprehensive support infrastructure, including dedicated 24/7 on-call clinical specialists, implementation experts, customer success teams, and a 'Viz Academy' for training. This is complemented by user guides and a knowledge base, indicating a strong commitment to customer support and documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Viz RV/LV VX1
Name Viz RV/LV VX1
Company Viz.ai Volta Medical
Description FDA-cleared AI algorithm that automates right and left ventricular diameter measurements from CTPA scans, providing a crucial RV/LV ratio for rapid pulmonary embolism risk stratification and enhanced care coordination within the Viz PE Solution. FDA-cleared AI software that assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures.
Primary Clinical Focus Pulmonary Embolism Risk Stratification (RV/LV ratio from CTPA) Atrial Fibrillation and Atrial Tachycardia Ablation Procedures (dispersed electrogram identification)
Specialties Emergency Medicine, Pulmonology, Radiology Cardiology

Videos

Demos, reviews, and walkthroughs featuring Viz RV/LV and VX1.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Viz RV/LV is designed for rapid pulmonary embolism (PE) risk stratification by automating right and left ventricular diameter measurements from CTPA scans, primarily benefiting emergency medicine, pulmonology, and radiology. In contrast, VX1 is an AI software that assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures.
Viz RV/LV functions as a seamless component of the Viz PE Solution, providing AI-powered alerts and a communication platform for care teams to streamline acute care workflows. VX1 is integrated with existing electrophysiology (EP) lab mapping and recording systems, offering real-time guidance during ablation procedures and is compatible with most EP recording, 3D navigation systems, and mapping catheters.
Viz RV/LV utilizes an AI algorithm for automated identification and measurement of heart ventricles from volumetric CTPA acquisitions, providing annotated images with measurements. VX1 offers AI-guided real-time identification of dispersed electrograms and includes a 'Booster mode' for increased sensitivity during atrial tachycardia or slow AF, aiming to reduce inter-operator variability and standardize outcomes.
Viz RV/LV's automated measurements and alerts within the Viz PE Solution are designed for rapid pulmonary embolism risk stratification, suggesting a quick time-to-value by enhancing care coordination. VX1 provides real-time assistance during complex ablation procedures, aiming to standardize outcomes and reduce inter-operator variability, which implies immediate value during each case for experienced electrophysiologists and allows for a fast learning curve.
Viz RV/LV provides annotated images showing ventricular measurements and an RV/LV Summary Report in DICOM format, which can serve as a record for clinical review and contribute to quality assessment. VX1's real-time analysis of 3D anatomical and electrical maps, coupled with its goal to reduce inter-operator variability and standardize outcomes, suggests it could generate data valuable for procedural standardization and quality improvement efforts.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.